3
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy

, , , &
Pages 550-555 | Published online: 07 Aug 2009

References

  • Lundorff P, Hahlin M, Sjoblom P, Lindblom B. Persistent trophoblast after conservative treatment of tubal pregnancy: prediction and detection. Obstet Gynecol 1991; 77: 129–33.
  • Hajenius PJ, Mol BWJ, Ankum WM, Van der Veen F, Bossuyt PM, Lammes FB. Clearance curves of serum human chorionic gonadotropin for the diagnosis of persistent trophoblast. Hum Reprod 1995; 10: 683–7.
  • Yao M, Tulandi T. Current status of surgical and non surgical management of ectopic pregnancy. Fertil Steril 1997; 67: 421–33.
  • Fernandez H, Marchal L, Vincent Y. Fertility after radical surgery for tubal pregnancy. Fertil Steril 1998; 70: 680–6.
  • Mol BW, Matthijsse HC, Tinga DJ, Hajenius PJ, Ankum WM, Bossuyt PM et al. Fertility after conservative and radical surgery for tubal pregnancy. Hum Reprod 1998; 13: 1804–9.
  • Lund CO, Nilas L, Bangsgaard N, Ottesen B. Persistent ectopic pregnancy after linear salpingotomy: a nonpredictable complication to conservative surgery for tubal gestation. Acta Obstet Gynecol Scand 2002; 81: 1053–9.
  • Hajenius PJ, Engelsbel S, Mol BW, Van der Veen F, Ankum WM, Bossuyt PM et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 1997; 350: 774–9.
  • Olofsson JI, Poromaa IS, Ottander U, Kjellberg L, Damber MG. Clinical and pregnancy outcome following ectopic pregnancy; a prospective study comparing expectancy, surgery and systemic methotrexate treatment. Acta Obstet Gynecol Scand 2001; 80: 744–9.
  • Midgley AR, Jaffe RB. Regulation of human gonadotropins. Disappearance of human chorionic gonadotropin following delivery. J Clin Endocrinol 1968; 28: 1712–18.
  • Holtz G. Human chorionic gonadotropin regression following conservative surgical management of tubal pregnancy. Am J Obstet Gynecol 1983; 147: 347–8.
  • Rizkallah T, Gurpide E, Vandewiele RL. Metabolism of hCG in man. J Clin Endocrinol 1969; 29: 92–100.
  • Kamrava MM, Taymor ML, Berger MJ, Thompson IE, Seibel MM. Disappearance of human chorionic gonadotropin following removal of ectopic pregnancy. Obstet Gynecol 1983; 62: 486–8.
  • La Sala GB, Torelli MG, Pagliani A, Borasi G, Dotti C. Human chorionic gonadotropin regression following removal of ectopic pregnancy. Acta Eur Fertil 1987; 18: 397–401.
  • Hellemans P, Gerris J, Joostens M, Van der Meer S, Verdonk P, Francx M et al. Serum hCG decline following salpingotomy or salpingectomy for extrauterine pregnancy. Eur J Obstet Gynecol 1994; 53: 59–64.
  • Mock P, Chardonnens D, Stamm P, Campana A, Bischof P. The apparent late half-life of human chorionic gonadotropin (hCG) after surgical treatment for ectopic pregnancy. A new approach to diagnose persistent trophoblastic activity. Eur J Obstet Gynecol Reprod Biol 1998; 78: 99–102.
  • Pouly JL, Mage G, Gachon F, Gaillard G, Bruhat MA. Decrease in the level of hCG after conservative laparoscopic treatment of ectopic pregnancy. J Gynecol Obstet Biol Reprod 1987; 16: 195–9.
  • Korhonen J, Alfthan H, Ylostalo P, Veldhuis J, Stenman UH. Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term. Pregnancy Clin Chem 1997; 43: 2155–63.
  • Vermesh M, Silva PD, Sauer MV, Vargyas JM, Lobo RA. Persistent tubal ectopic gestation; pattern of circulating beta-human chorionic gonadotropin and progesterone, and management options. Fertil Steril 1988; 50: 584–8.
  • Pouly JL, Mahnes H, Mage G, Canis M, Bruhat MA. Conservative laparoscopic treatment of 321 EP. Fertil Steril 1986; 46: 1093–7.
  • Pouly JL, Chapron C, Mage G, Manhes H, Wattiez A, Canis M et al. The drop in the level of hCG after conservative laparoscopic treatment of ectopic pregnancy. J Gynecol Surg 1991; 7: 211–7.
  • Seifer DB, Gutmann JN, Doyle MB, Jones EE, Diamond MP, DeCherney AH. Persistent ectopic pregnancy following laparoscopic linear salpingostomy. Obstet Gynecol 1990; 76: 1121–5.
  • Bouyer J, Job-Spira N, Pouly JL, Coste J, Germain E, Fernandez H. Fertility following radical, conservative- surgical or medical treatment for tubal pregnancy: a population-based study. Br J Obstet Gynaecol 2000; 107: 714–21.
  • Bonatz G, Lehmann-Willenbrock E, Kunstmann P, Semm I, Hedderich J, Semm K. Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy. Int J Gynecol Obstet 1994; 47: 33–8.
  • Hagstrom HG, Hahlin M, Bennegard-Eden B, Sjoblom P, Thorburn J, Lindblom B. Prediction of persistent EP after laparoscopic salpingostomy. Obstet Gynecol 1994; 84: 798–802.
  • Spandorfer SD, Sawin SW, Benjamin I, Barnhart KT. Postoperative day 1 serum human chorionic gonadotropin level as a predictor of persistent ectopic pregnancy after conservative surgical management. Fertil Steril 1997; 68: 3430–4.
  • Seifer DB. Persistent ectopic pregnancy: an argument for heightened vigilance and patient compliance. Fertil Steril 1997; 68: 402–4.
  • Graczykowski JW, Mishell DR. Methotrexate prophylaxis of persistent ectopic pregnancy after conservative treatment by salpingostomy. Obstet Gynecol 1997; 89: 118–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.